MedTrace Logo

Bangladesh Vitamin E and Selenium Trial

NCT00392561 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 7000

Last updated 2023-04-26

No results posted yet for this study

Summary

The purpose of this study is to evaluate whether selenium and/or vitamin E are effective in preventing non-melanoma skin cancers.

Conditions

  • Non-melanoma Skin Cancer

Interventions

DIETARY_SUPPLEMENT

Selenium

200 ug Selenium daily

DIETARY_SUPPLEMENT

vitamin E

100 mg Vitamin E daily

Sponsors & Collaborators

  • Columbia University

    collaborator OTHER

  • Dartmouth-Hitchcock Medical Center

    collaborator OTHER

  • International Centre for Diarrhoeal Disease Research, Bangladesh

    collaborator OTHER

  • University of Chicago

    lead OTHER

Principal Investigators

  • Habibul Ahsan, MD · University of Chicago

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
TRIPLE
Model
FACTORIAL

Eligibility

Min Age
25 Years
Max Age
65 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2006-04-01
Primary Completion
2021-08-19
Completion
2021-08-19

Countries

  • Bangladesh

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00392561 on ClinicalTrials.gov